Ancillary Care Management Helps Plans and Physicians Prepare for the Synagis(R) Season

MINNEAPOLIS, Sept. 18 /PRNewswire/ -- Ancillary Care Management, Inc. (ACM) today announced the details of its latest program innovation that helps ensure consistent delivery and availability of the product Synagis(R) -- the leading drug in the marketplace used to prevent serious illness in infants and babies at risk for severe respiratory syncytial virus (RSV) infection.

Leveraging ACM's clinical expertise and state-of-the-art technology, a fully-scalable and flexible benefit authorization system incorporates a variety of plan-defined criteria to create a stand-alone, modular program that continues to place the company and its benefit management solutions at the forefront of the industry. For all Synagis(R) drug requests, for example, ACM brings together a suite of technology-driven tools to manage authorizations and eligibility and deliver an automated letter management system for improved communication between plans and physicians, members and patients.

"With this Synagis(R) program, ACM is again demonstrating our corporate commitment to provide powerful technology, unparalleled service, and unique products that will enhance the quality, speed, and cost-effectiveness of patient care," according to Gary A. Loeber, R.Ph., ACM's Executive Vice President of Business Development. "Our clinical initiatives and unique set of services put us in a great position to reach out to plans and members, work with physicians and providers, and contribute to ensuring that patients receive the medications they need, when they need them."

The full capabilities of ACM's completely-automated program for Synagis(R) streamline the authorization process and provide the clinical coordination needed to:

  --  Authorize a complete season of treatment-in just one online
      transaction -- and get reorders processed quickly and efficiently
      against the initial authorization
  --  Auto-generate customized letters to physicians and members,
      accommodating multiple languages and state requirements to achieve
      compliance
  --  Create authorization protocols that incorporate plan-specific
      requirements, clinical criteria, or regional variations in time and
      duration of the RSV season
  --  Eliminate time-consuming and expensive paper-based processing to
      achieve administrative cost-efficiencies and uniformity in benefit
      authorizations

To learn more about ACM's other programs and services, and how ACM can impact your bottom line, visit http://www.acmcentral.com/ .

About ACM

Ancillary Care Management empowers clients to improve the management of ancillary services through technology-enabled solutions that enhance the quality, speed, and cost effectiveness of patient care. With over 35 million lives under contract, ACM manages High Touch Specialty and Infusion Pharmaceuticals, Home Nursing, Home Medical Equipment, and Respiratory Services.

ACM is URAC-accredited for health utilization management and offers solutions that link participants in the complex ancillary benefits environment through a suite of Web-based tools, accessible through http://www.acmcentral.com/ .